Trial intelligence / Profile preview

Effect of Tetrahydrocannabinol on Ocular Hemodynamics in Healthy Subjects

2017-004852-52Phase 2Completed

Sponsor
Medical University of Vienna
Start
Mar 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, single-arm trial of dronabinol, sponsored by Medical University of Vienna. Primary endpoint: Optic nerve head blood flow. Started Mar 2018; status: completed.

02

Drugs

dronabinol

Beyond the preview

Go deeper on 2017-004852-52.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2017-004852-52.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call